share_log

BMO Capital Maintains Outperform on TrueBlue, Lowers Price Target to $13

Benzinga ·  May 8 07:53

BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and lowers the price target from $15 to $13.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment